Joseph B. Fetterman
Executive Vice President, Colliers Life Sciences Practice Group

Joe joined Colliers International in 2012 to lead and grow Colliers’ Office Brokerage Division. Today he focuses on providing strategic solutions to local and national Health Care and Life Science clients. Joe’s background in architecture, real estate development and financial analysis provides clients with an experienced professional and strategic leader who integrates complex factors to create successful results for clients.

Joe is a Healthcare Fellow and serves on the Colliers National Healthcare Services Steering Committee and the Colliers Life Sciences Practice Group Steering Committee.

​

Prior to joining Colliers, Joe was Senior Vice President in the Philadelphia office of Jones Lang LaSalle, leading the company’s regional higher education and healthcare consulting and brokerage practices.Joe has managed the acquisition, leasing, design, construction and occupancy of more than 4,000,000 SF of office space on behalf of clients and performed consulting studies for numerous institutional clients in the region. ​He has sold, leased or developed many iconic properties including NFL Films’ Production Studio, Tyco International’s HQ at 57 W. 57th Street in Manhattan, The Wistar Institute’s 1895 Building and new research tower at 36th & Spruce, Hillel at Penn (Steinhardt Hall) at 37th and Locust Walk and 3600 and 3615 Market Street.

Christopher P. Molineaux
President & CEO, Life Sciences Pennsylvania

As president & CEO of Life Sciences Pennsylvania, Christopher Molineaux serves as the chief advocate and spokesman for the life sciences industry that calls Pennsylvania home.  Molineaux oversees the strategic direction for the association, assuring Life Sciences Pennsylvania continues to be the catalyst that makes Pennsylvania the top location for life sciences companies. 

Molineaux brings to Life Sciences Pennsylvania nearly 30 years of experience in the bio-pharmaceutical and health care industries, with front-line experience in developing and executing strategies to navigate a shifting economic and political environment. 

Prior to joining Life Sciences Pennsylvania in September 2009, Molineaux served as worldwide vice president of pharmaceutical communications and public affairs for Johnson & Johnson.  He began his Johnson & Johnson career as vice president of corporate communications at Centocor in Malvern, PA, and was later promoted to vice president for communications of Johnson & Johnson’s global Biotechnology, Immunology & Oncology (B.I.O.) business unit.
​
Molineaux previously served as vice president of public affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA).  Prior to his role at PhRMA, he was vice president, communications and marketing at the Blue Cross and Blue Shield Association, developing public awareness and education strategies related to commercial and government payer systems.  Molineaux also worked as a public affairs executive for the federal Departments of Health and Human Services (HHS) and Agriculture, and as a press officer on the White House staff of President George H. W. Bush.
​
In addition to leading Life Sciences Pennsylvania, Chris Molineaux serves as Chairman of the Board of Directors of Aclaris Therapeutics, Inc. (NASDAQ: ACRS); a non-executive director of NexEos Bio; on the Board of Directors of the Chester County Economic Development Council; and on the Valley Forge Tourism & Convention Board.  He also serves on the Advisory Boards of BioAgilytix Labs of Durham, NC and St. John Vianney Church of Gladwyne, PA.

Anne-Marie Maman
Director, Princeton Entrepreneurship Council at Princeton University

Anne-Marie Maman is Executive Director of the Princeton Entrepreneurship Council, which works to engage and educate Princeton-connected entrepreneurs of all levels, on campus, in our community, and in locations around the world. PEC is also actively engaged with the greater NJ entrepreneurial ecosystem, and in Princeton’s outreach to underappreciated academic founders from all communities.

Anne-Marie spent most of her career commercializing medical technologies - starting in large international companies, moving to medical device startups, and then becoming an entrepreneur herself. Her passion was improving patient care by matching specific market needs with effective products. As the business founder of her startups, she brought general business and fundraising experience and a specialty in ensuring strong product/market fit.
 
Anne-Marie has an AB from Princeton University in English, and an MBA from the Kellogg School of Management at Northwestern University in marketing and finance.

Louis P. Kassa
Executive Vice President/Chief Operating Officer, Pennsylvania Biotechnology Center
 

Louis P. Kassa III has been Chief Operating Officer of the Pennsylvania Biotechnology Center (PABC), Baruch S. Blumberg Institute and Hepatitis B Foundation since December 2014. Kassa oversees daily operations, finance, business development and compliance at the PABC, which is home to the Hepatitis B Foundation and its research entity, the Blumberg Institute. In 2017, Kassa was promoted to Executive Vice President/Chief Operating Officer. From 2015 to 2017, Kassa worked part-time as the Chief Executive Officer for Youth Services Agency, a non-profit social services agency.  In 2017, Kassa co-founded Family Foundations Partnership and is currently the Chief Executive Officer. 

He previously served as State Director and Chief Operating Officer at VisionQuest National Ltd., a national behavioral health company. In 2020, Kassa was named one of “The 10 Best COO’s of 2020” by Industry Era, a global technology media outlet. Kassa received his undergraduate degree from Penn State University and received a Masters in Public Administration from Villanova University in 2007.

Event Emcee: 

Grant Castor

Grant Castor is the Vice President of Commercial Operations for Sentynl Therapeutics. Sentynl Therapeutics is a San Diego based specialty pharmaceutical company that acquires, develops and commercializes prescription products focused on a variety of genetic orphan and neurological disorders. Commercializing its first asset in 2015 Sentynl was successfully acquired by Zydus Pharmaceuticals in 2017. Prior to Sentynl; Mr. Castor managed marketing for the Brand and Authorized Generic portfolios of Amedra Pharmaceuticals and Lineage Therapeutics. Amedra Pharmaceuticals, Lineage Therapeutics, and Corepharma were successfully sold to Impax Laboratories in 2015.

Prior to Amedra, Mr. Castor was head of U.S. operations and global marketing for an Israel based medical device start-up that successfully commercialized a novel orthopedic device in 30 + countries. Mr. Castor began his career “carrying the bag” for a distributor of Zimmer Spine implants and Osteotech Orthobiologics (Acquired by Medtronic in 2010).

In addition to leading Commercial Operations for Sentynl Therapeutics, Mr. Castor is an active volunteer firefighter in the Doylestown Community, is very active in the local biotech community, and provides mentorship to entrepreneurs. He earned his B.S. in International Business from Johnson & Wales University.